Anzeige
Mehr »
Login
Freitag, 25.04.2025 Börsentäglich über 12.000 News von 692 internationalen Medien
Jetzt knallt's an der Börse! Diese Aktie hat das Zeug zum Überflieger!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
246 Leser
Artikel bewerten:
(1)

US Ultrasound Market worth US$3.82 billion by 2030 with 7.6% CAGR | MarketsandMarkets

Finanznachrichten News

DELRAY BEACH, Fla., April 15, 2025 /PRNewswire/ -- The US Ultrasound Market is projected to reach US$3.82 billion by 2030 from US$2.46 billion in 2024, at a CAGR of 7.6%. The US ultrasound market is growing due to AI-integrated ultrasound imaging advancements, the increasing adoption of portable ultrasound devices, the growing incidence of chronic diseases, and the expanding applications in point of care (PoC) and emergency medicine. The growing use of ultrasound in pain management and rehabilitation and rising investments in R&D for contrast enhanced ultrasound (CEUS)is also supporting market growth.

MarketsandMarkets Logo

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=467

Browse in-depth TOC on "US Ultrasound Market"

400 - Tables
45 - Figures

By Based on segment, In the US, the ultrasound market is classified based on display into colour ultrasound and black & white ultrasound. In 2025, the colour ultrasound segment accounted for the largest share of the display segment. The high demand for colour ultrasound is attributed to being the most importantly used display in diagnosis cases related to cardiovascular disorder diagnosis and monitoring pregnancy in obstetrics and examining vascular disease, increased rates of chronic diseases, particularly heart disease and diabetes that may have complications of the vessels, and greater high-resolution, real-time images producing capabilities thus improving diagnostic efficacy for diverse applications.

By Based on technology, the US ultrasound market is segmented into diagnostic ultrasound and therapeutic ultrasound. The diagnostic ultrasound segment is expected to register the highest growth rate during the forecast period due to the significant usage of 2D ultrasound in women's health, the availability of medical reimbursements for diagnostic ultrasound procedures in the US market, improved diagnosis with 3D ultrasound technology, and the growing applications of emerging ultrasound techniques (such as Doppler ultrasound in vascular imaging and 3D/4D ultrasound in oncology).

By application, the US ultrasound market is segmented into radiology/general imaging, cardiology, ob/gyn, urology, vascular, orthopaedic & musculoskeletal, pain management, paediatric and other applications. Some key factors propelling the segment expansion are increasing prevalence of cardiovascular disease across major US healthcare markets, widespread adoption in diagnosis and treatment of urological disorders and rising incidence of osteoarthritis. Additionally, advancements in AI-powered ob/gyn ultrasound, the growing adoption of portable ultrasound for pain management and increased use of paediatric ultrasound to combat neonatal mortality are driving the growth of segment during forecast period.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=467

Prominent players in the ultrasound market include Philips Healthcare (Netherlands), GE Healthcare (US), Canon Medical Systems Corporation (Japan), Siemens Healthineers (Germany), FUJIFILM Holdings Corporation (Japan).

For more information, Inquire Now!

Related Reports:

Endoscopic Ultrasonography (EUS) Market

Ultrasound Needle Guides Market

Ablation Technology Market

Diagnostic Imaging Market

Medical Image Analysis Software Market

About MarketsandMarkets:

MarketsandMarkets has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore, which integrates research and provides ecosystem-wide visibility into revenue shifts.

In addition, MarketsandMarkets SalesIQ enables sales teams to identify high-priority accounts and uncover hidden opportunities, helping them build more pipeline and win more deals with precision.

To find out more, visit www.MarketsandMarkets.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/

Logo: https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/us-ultrasound-market-worth-us3-82-billion-by-2030-with-7-6-cagr--marketsandmarkets-302428657.html

© 2025 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.